Skip to content

Digital-Health-Glossary-IGR-PV-Topic-8-_final_version01

Related Blog Posts

Science is Moving—Clinical Trials Must Catch Up

Digital-Health-Glossary-IGR-PV-Topic-8-_final_version01 Clinical research has never been more capable of reaching new frontiers. The science is here. The technology is here. But the approach to trial design and execution hasn’t kept pace. The clinical research ecosystem proceeds cautiously for good reasons—patient safety chief among them. But too often, we’re held back by fixed mindsets and outdated…

The Impact of ICH E6(R3) – Sponsor and CRO Perspectives

Digital-Health-Glossary-IGR-PV-Topic-8-_final_version01 In ACRO and TransCelerate BioPharma’s latest collaboration, Cris McDavid (Senior Director, Global Clinical Operations, Parexel) and Tashan Mistree (Senior Director, Business Operations, Office of Chief Medical Officer, GSK) join this week’s episode to discuss the impact of ICH E6(R3) from their different vantage points in the clinical research industry. Listen to the podcast by Cris McDavid and Tashan…

Unifying Industry to Better Understand GCP Guidance

Digital-Health-Glossary-IGR-PV-Topic-8-_final_version01 In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better…